The activities of 3-hydroxyacyl-CoA dehydrogenase, enoyl-CoA hydratase, and 3-ketoacyl-CoA thiolase were measured in fibroblasts from eight patients with 3-hydroxydicarboxylic aciduria. Measurement of 3-hydroxyacyl-CoA dehydrogenase with 3-ketopalmitoyl-CoA as substrate provided conclusive evidence for a deficiency of the longchain 3-hydroxyacyl-CoA dehydrogenase in seven of the patients. Measurement of the enzyme in the normal direction cannot be recommended because this gives a higher residual activity. A trifunctional enzyme protein is responIn recent years, an increasing number of inherited diseases in humans in which there is an impairment in mitochondrial P-oxidation have been recognized (1, 2). Defects of several enzymes of p-oxidation such as the long-chain, medium-chain, and short-chain acyl-CoA dehydrogenases have been described (1, 2). Recent studies on 3-hydroxydicarboxylic aciduria showed that many but not all of the patients who are characterized by the massive excretion of 3-hydroxydicarboxylic acids have deficient activity of the mitochondrial LCHAD (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . Moreover, LCHAD seems to be associated with a trifunctional enzyme having also enoyl-CoA hydratase and 3-ketoacyl-CoA thiolase activity (13) (14) (15) .
Previously, we have reported clinical data on five children with 3-hydroxydicarboxylic aciduria with a suspected defect in mitochondrial p-oxidation, possibly at the level of the 3-hydroxyacyl-CoA dehydrogenase (4). The clinical features described in these patients include hypoglycemia, myopathy, cardiomyopathy, fatty infiltration of the liver, peripheral neuropathy, and pigmentary retinopathy (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) . In this report, assays of 3-hydroxyacyl-CoA dehydrogenase, enoyl-CoA hy-sible for the 3-hydroxyacyl-CoA dehydrogenase as well as for the hydratase and thiolase activities. A slight decrease in one or both of the other two activities was observed in four of the seven deficient patients, indicating that a defect in the trifunctional enzyme protein may affect the three enzyme activities to different degrees. (Pediah Res 36:
111-114, 1994)
Abbreviations LCHAD, long-chain 3-hydroxyacyl-CoA dehydrogenase dratase, and 3-ketoacyl-CoA thiolase activities in cultured fibroblast provide conclusive evidence for a deficient activity of LCHAD in four of the five reported cases and in three additional new cases of 3-hydroxydicarboxylic aciduria. Similarly, in four of the seven patients with LCHAD deficiency, we observed slight decreases in enoyl-CoA hydratase o r 3-ketoacyl-CoA thiolase activities.
METHODS

Subjects.
Skin biopsies were obtained from eight patients with defects in the oxidative metabolism of fatty acids, three males (patients 1, 6, and 8) and five females (patients 2, 3, 4, 5, and 7). All patients had 3-hydroxydicarboxylic aciduria, and clinical data on five patients (patients 1 through 5) have been published earlier (4) . Four of these patients died between the 4th and 16th mo of age because of liver failure and cardiomyopathy. The remaining four patients (patients 5 through 8) are still alive. Clinical data for the last three patients will be published elsewhere.
Chemicals and culture media. All growth media and antibiotics were obtained from Gibco BRL (Life Technologies, European Division), and enzymes were obtained from Boehringer Mannheim GmbH (Mannheim, Germany). Acyl-CoA and other chemicals were purchased from Sigma (St. Louis, MO). The 3-ketoacyl-CoA and 2-enoyl-CoA esters were synthesized enzymatically (as detailed below).
Cell culture. Fibroblasts were cultured from skin biopsies using Eagle's minimum essential medium containing FCS (lo%, vol/vol), penicillin (125 IU/mL), streptomycin (125 kg/mL), and Tylocine [6 mg/mL (anti-PPLO agent); Gibco BRL]. Stock cultures of individual fibroblast strains were cultured in 75-cm2 plastic tissue culture flasks in a humidified atmosphere of 5% C02 in air at 37°C. Fibroblast lines were used between the 8th and 16th passage. The cells were frequently checked for mycoplasma and bacterial contamination.
Preparation of 3-ketoacyl-CoA and 2-enoyl-CoA. The 3-ketooctanoyl-CoA, 3-ketolauroyl-CoA, and 3-ketopalmitoyl-CoA substrates were synthesized enzymatically from octanoyl-CoA, lauroyl-CoA, and palmitoylCoA by using commercially available acyl-CoA oxidase, crotonase, and 3-hydroxyacyl-CoA dehydrogenase and purified as described elsewhere (16) .
Enzyme assays. The activity of 3-hydroxyacyl-CoA dehydrogenase in fibroblast homogenates was measured in the "reverse" direction as described by Wanders et al. (5) . The assay mixture contained 50 mmol/L 2-(Nmorpholino)ethanesulfonic acid, 100 mmol/L potassium phosphate, 0.1% (wtlvol) Triton X-100, 100 pmol/L NADH (final pH = 6.16), and fibroblast homogenate. Reactions were started by adding 3-oxoacyl-CoA ester at a final concentration of 50 p.mol/L for acetoacetyl-CoA (C4) and 40 kmol/L for 3-keto-palmitoyl-CoA (C16).
The 3-hydroxyacyl-CoA-dependent NAD+ reduction (forward reaction) was assayed with enoyl-CoA as substrate in the presence of crotonase (17) . A solution containing 0.1 mol/L Tris-KC1 (pH 10.2), 0.6 IU/mL crotonase, and 50 pmol/L 2-enoyl-CoA in a total volume of 0.8 mL was incubated for 3 min. Cell homogenate was then added, the reaction was started by adding 1 mmol/L NAD+, and the increase in absorbance at 340 nm was followed.
The short-chain 3-ketothiolase activity was measured at 37°C in homogenates of cultured skin fibroblasts by following the decrease in absorbance at 303 nm using a medium containing 100 mmol/L Tris-HC1 (pH 8.05), 10 mmol/L MgCI,, 50 mmol/L KC1 (if added), 50 kmol/L CoA, 50 kmol/L acetoacetyl-CoA, and 0.1% (wt/vol) Triton X-100 (5).
The long-chain 3-ketothiolase activity was determined in the presence of 25 mmol/L MgCI,, 75 kmol/L CoA, 10 kmol/L 3-ketohexadecanoyl-CoA, and 0.2 mg/mL BSA. Reactions were started after preincubation for 2 min by adding CoA.
The enoyl-CoA hydratase activity was measured at 37°C by following the increase in absorbance at 365 nm. A solution containing 100 mmol/L Tris-HC1 (pH 8.0), 0.1 % (wttvol) Triton X-100, 1 mmol/L 3-acetylpyridine adenine dinucleotide, 7.1 IU/mL 3-hydroxyacyl-CoA dehydrogenase, and fibroblast homogenate was preincubated for 2 min. The reaction was then started by adding 0.1 mmol/L substrate (2-enoyl-CoA) (16) .
RESULTS
The third reaction of @-oxidation is the reversible dehydrogenation of 3-hydroxyacyl-CoA to 3-ketoacyl-CoA catalyzed by 3-hydroxyacyl-CoA dehydrogenase. In the present study, the activity of this enzyme was determined in both directions. In the reverse reaction, 3-oxoacylCoA with chain lengths of four, eight, and 16 carbon atoms were used as substrates. The results (Table 1) show that fibroblasts from seven of eight patients with 3-hydroxydicarboxylic aciduria had strongly reduced activities when the C16 substrate was used (11 * 2 compared with 50 + 6 nmol/min/mg protein for the controls).
The average residual activity was 22% of the control mean. The decrease was less pronounced with C, substrate (59% of control mean), and the activity was normal with C,. Similar results were obtained when 3-hydroxyacyl-CoA dehydrogenase was measured in the forward direction using 3-hydroxybutyryl-CoA (C,), 3-hydroxylauryl-CoA (C12), and 3-hydroxypalmitoyl-CoA (C,,) as substrates ( Table 1 ). The activities measured with the forward assay were generally lower than those of the reverse assay. The differences between patients and controls were also less pronounced with the forward assay. The C,, activity in the patients was, on the average, decreased to 48% of the mean of controls when measured in the forward direction.
With long-chain substrates, the activities were also decreased to slightly below the control mean minus 2 SD for the enoyl-CoA hydratase in three patients (patients 3, 4, and 8) and for 3-ketothiolase in three patients (patients 3, 4, and 7; Tables 2 and 3 ). Addition of activator (50 mmol/L KCI) caused an increase in the activity of shortchain 3-ketothiolase to a similar extent in both patients and controls (81 and 89%, respectively). 
DISCUSSION
We have previously described five patients with 3-hydroxydicarboxylic aciduria with early onset of hypoketotic hypoglycemia. Four of the patients died at the age of 4-16 mo with fat infiltration in liver and heart (4). Three additional patients with similar clinical presentation have since been observed. The characteristic biochemical findings of a massive excretion of 3-hydroxydicarboxylic acids in the urine and the accumulation of 3-hydroxy fatty acids in serum during acute illness in the patients led us to suspect a defect in mitochondrial p-oxidation. Our previous results (4) showed that the metabolic defect was not at the level of the acyl-CoA dehydrogenases.
We have now shown that four of these patients had a deficiency of LCHAD. The patient with normal LCHAD activity (patient 5 in ref. 4 ) had a urinary excretion pattern similar to that of the other patients with 3-hydroxydicarboxylic aciduria. The clinical presentation was, however, somewhat different. She was the only of the five original patients that survived into childhood (she is still alive). She also had more severe neurologic symptoms than the others (abnormal EEG, seizures, transient hemiparesis). Moreover, the rate of palmitate oxidation in intact fibroblasts from this patient was in the low normal range (unpublished data). This girl may have a respiratory chain defect, but it has not been possible to make any further investigations regarding this. The findings in this girl demonstrate that 3-hydroxydicarboxylic aciduria may be caused by conditions other than LCHAD deficiency.
In the present study, the activities of 3-hydroxyacylCoA dehydrogenase in homogenates of cultured fibroblasts were assayed in both directions (forward and reverse) using substrates of different chain lengths. A considerable rest activity was observed in fibroblasts from the deficient patients with C16 substrates, accounting for 22% in the reverse and 48% in the forward reaction. There are several possible sources for this remaining LCHAD activity. First, the assays were performed in total homogenates of fibroblasts, and activities from the genetically separate peroxisomal p-oxidation enzymes may have been included. Recent immunoprecipitation studies by Jackson et al. (18) suggest that the high level of residual activity is almost completely caused by shortchain 3-hydroxyacyl-CoA dehydrogenase, which also reacts with the C16 substrate. Recent gel filtration experiments (16) support this notion.
The mitochondrial, membrane-bound LCHAD activity in both rat (14) and human (15) liver is associated with a trifunctional enzyme having also enoyl-CoA hydratase and 3-ketoacyl-CoA thiolase activity. The enzyme is composed of two nonidentical subunits in both species. Comparing the ratios between the three activities measured in the purified enzyme (15) with the ratios observed in control fibroblasts in the present study, it appears possible that this trifunctional enzyme is responsible for a major part of all three activities that we have measured with long-chain substrates. Inasmuch as the enzyme is a heterotetramer, it is conceivable that different mutations could affect the three separate activities to different degrees. The slight decrease in enoyl-CoA hydratase and 3-ketoacyl-CoA thiolase activities observed in some of our patients could be explained in this way. Inasmuch as the patients were selected because they excreted 3-hydroxydicarboxylic acids, it is not surprising that the 3-hydroxyacyl-CoA dehydrogenase activity was the most severely affected in all of them.
